Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Baxter International, Inc. (NYSE: BAX).

Full DD Report for BAX

You must become a subscriber to view this report.


Recent News from (NYSE: BAX)

Baxter announces FDA clearance of new Spectrum IQ Infusion System
Baxter International (NYSE: BAX ) announces the FDA clearance of the Spectrum IQ Infusion System with Dose IQ Safety Software. More news on: Baxter International Inc, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 14 2018 08:55
Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System
Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation Offers First-of-Its-Kind Software Technology and Simple, Standardized User Experience to Help Reduce Programming Errors and Enhance Patien...
Source: Business Wire
Date: May, 14 2018 08:31
Baxter International (BAX) Investor Presentation - Slideshow
The following slide deck was published by Baxter International Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: May, 08 2018 14:47
Baxter declares $0.19 dividend
Baxter (NYSE: BAX ) declares $0.19/share quarterly dividend , 18.8% increase from prior dividend of $0.16. More news on: Baxter International Inc, Dividend News, Read more ...
Source: SeekingAlpha
Date: May, 08 2018 09:05
Baxter Declares Dividend and Announces Quarterly Dividend Increase
Baxter International Inc. (NYSE:BAX) today announced an approximately 19% increase in the company’s quarterly dividend rate. This rate increase was made in connection with the declaration of a quarterly cash dividend of $0.19 per share of common stock (up from $0.16 per share), payabl...
Source: Business Wire
Date: May, 08 2018 09:00
McKesson To Acquire MSD For Medical Supply Distribution
Quick Take McKesson ( MCK ) has announced an agreement to acquire Medical Specialties Distributors [MSD] for $800 million. MSD has developed a distribution network for medical-surgical and infusion supplies and biomedical services. MCK continues to acquire firms to expand its footp...
Source: SeekingAlpha
Date: May, 07 2018 14:49
Valuation Dashboard: Healthcare - Update
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology is undervalued regarding historical averages in Price/Earnings and Pr...
Source: SeekingAlpha
Date: May, 07 2018 13:37
Bright Lights On Capitalist Woodstock, Tech Developers And Sports Betting
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Macro matters: Traders are back to focusing on economic reports after no major deve...
Source: SeekingAlpha
Date: May, 05 2018 08:33
Biotech Industry Presses Forward with Latest Transdermal Drug Delivery Advancements
Palm Beach, FL – (May 3, 2018) – The multi-billion dollar Biotech Industry is witnessing a transformation as it relates to the advancement of transdermal drug delivery patches. On the back of factors like rising number of transdermal drug delivery products, enhanced awareness in de...
Source: MarketNewsUpdates.com
Date: May, 03 2018 08:50
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
Five-year agreement supports access to cost-effective, integrated renal care through awareness building, education and research, particularly in low- and middle-income countries Efforts include focus on unmet need to diagnose and treat chronic kidney disease earlier to help slow dis...
Source: Business Wire
Date: May, 02 2018 08:30

 


About Baxter International, Inc. (NYSE: BAX)

Logo for Baxter International, Inc. (NYSE: BAX)

Not available

 

Contact Information

 

 

Current Management

  • Robert Parkinson / CEO, Principal Executive Officer
  • Robert J Hombach / CFO, Treasurer
  • David P. Scharf / Vice President, Secretary
  • Robert Parkinson / Chairman

Current Share Structure

  • Market Cap: $38,090,589,234 - 05/11/2018
  • Issue and Outstanding: 540,138,815 - 01/31/2018

 


Recent Filings from (NYSE: BAX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 23 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 23 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 01 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 29 2018

 

 


Daily Technical Chart for (NYSE: BAX)

Daily Technical Chart for (NYSE: BAX)


Stay tuned for daily updates and more on (NYSE: BAX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: BAX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BAX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of BAX and does not buy, sell, or trade any shares of BAX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/